Get the Stockscreener App
6.96
0.14%
0.010
Teladoc Health Inc stock is traded at $6.96, with a volume of 5.99M.
It is up +0.14% in the last 24 hours and down -18.21% over the past month.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
See More
Previous Close:
$6.95
Open:
$6.96
24h Volume:
5.99M
Relative Volume:
0.89
Market Cap:
$1.23B
Revenue:
$2.59B
Net Income/Loss:
$-981.73M
P/E Ratio:
-1.2062
EPS:
-5.77
Net Cash Flow:
$206.95M
1W Performance:
+0.29%
1M Performance:
-18.21%
6M Performance:
-46.25%
1Y Performance:
-3.47%
1-Day Range:
$6.85
$7.0975
1-Week Range:
$6.77
$7.15
52-Week Range:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
6.96 | 1.24B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
282.13 | 46.19B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
60.87 | 9.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.58 | 10.89B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.05 | 7.86B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.59 | 5.92B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-25 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Telemedicine Technologies Market Size Growth Trends Report 2035 - MarketReports.us
Revolutionizing Success in the Combined Telehealth - openPR.com
Hinge Health's Post-IPO Surge: A Test of Fundamentals in the Digital Therapeutics Gold Rush - AInvest
Amwell's Strategic Reinvention: Can Narrowing EBITDA Losses and Subscription Growth Fuel Long-Term Value in the Mental Health Tech Sector? - AInvest
Unexpected Trends Reshaping the U.S. Telemedicine Market - openPR.com
How the U.S. Telehealth Market Will Evolve by 2032Growth, - openPR.com
Global Telemedicine Market: Unxpected Growth in Digital Healthcare Delivery & Remote Care | 2025-2032 - openPR.com
Global Telehealth Market: Evolving Patient-Centric Platforms Driving Healthcare Transformation | 2025-2032 - openPR.com
Does Teladoc Health Inc. stock perform well during market downturnsHarness the power of proven investment plans - Jammu Links News
What are the technical indicators suggesting about Teladoc Health Inc.Build wealth faster with consistent investment plans - Jammu Links News
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses - MSN
How strong is Teladoc Health Inc. company’s balance sheetOutstanding capital appreciation - Jammu Links News
What is Teladoc Health Inc. company’s growth strategyGet exclusive market insights for better trading - Jammu Links News
What are the latest earnings results for Teladoc Health Inc.Skyrocketing investment returns - Jammu Links News
How volatile is Teladoc Health Inc. stock compared to the marketAchieve rapid portfolio appreciation today - Jammu Links News
Should I hold or sell Teladoc Health Inc. stock in 2025Capitalize on emerging growth stocks - Jammu Links News
How does Teladoc Health Inc. generate profit in a changing economyCapitalize on stocks with high profit margins - Jammu Links News
What makes Teladoc Health Inc. stock price move sharplyCapitalize on market momentum for maximum gains - Jammu Links News
Is Teladoc Health Inc. a growth stock or a value stockMaximize gains with strategic stock entries - Jammu Links News
When is Teladoc Health Inc. stock expected to show significant growthFree Wealth Planning Blueprint - Jammu Links News
What analysts say about Teladoc Health Inc. stockUncover the best stocks for explosive growth - Jammu Links News
What drives Teladoc Health Inc. stock priceMaximize returns with disciplined trading approaches - Jammu Links News
What catalysts could drive Teladoc Health Inc. stock higher in 2025Massive portfolio appreciation - Jammu Links News
Teladoc's Mixed Performance: Solid Integrated Care Growth Amid BetterHelp Challenges and Macroeconomic Pressures. - AInvest
Mixed Analyst Opinions on Healthcare Stocks: Teladoc, Ionis Pharmaceuticals, and Repligen - AInvest
Digital Health Market Set to Witness Significant Growth by 2025-2032 | Teladoc Health, American Well Corporation - openPR.com
Upcoming Opportunities in Pediatric Telehealth Visits Market: - openPR.com
Telehealth Heats Up With Teladoc, Livongo Health $18B Merger - PYMNTS.com
Teladoc Health rises on results beat, guidance announcement - MSN
Teladoc beats Wall Street expectations in Q2 amid strategic revamp - Healthcare Dive
Is it the right time to buy Teladoc Health Inc. stockFinancial News Report For Fast Growth - Jammu Links News
Teladoc Health, Inc. (NYSE:TDOC) Q2 2025 Earnings Call Transcript - Insider Monkey
The Teladoc Health, Inc. (NYSE:TDOC) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st
Analysts Have Made A Financial Statement On Teladoc Health, Inc.'s (NYSE:TDOC) Second-Quarter Report - Yahoo Finance
Teladoc Health likely to post a Q2 loss and year-over-year decline in revenue - MSN
Teladoc Health Inc. stock chart pattern explainedLong Hold Safe Return Strategy Reviewed - metal.it
Teladoc (TDOC) Q2 Revenue Tops Estimates - AOL.com
Teladoc Inc. Earnings Call: Growth Amid Challenges - MSN
Teladoc Health 2025 Q2 Earnings Net Income Surges 96.1% - AInvest
Teladoc (TDOC) Q2 Revenue Tops Estimates - The Motley Fool
Teladoc Health, Inc. SEC 10-Q Report - TradingView
Teladoc (TDOC) Stock Is Up, What You Need To Know - Yahoo Finance
Teladoc Health: Still Struggling To Find A Catalyst (NYSE:TDOC) - Seeking Alpha
Teladoc stock holds steady as Stifel maintains $8 price target By Investing.com - Investing.com Nigeria
Teladoc stock holds steady as Stifel maintains $8 price target - Investing.com
Digital Health Market is evolving rapidly Through 2025 To 2032 | - openPR.com
Teladoc Health Q2 2025 net loss hits USD 32.7 million - Medical Buyer
Needham reiterates Hold rating on Teladoc stock after Q2 results By Investing.com - Investing.com UK
Teladoc Beats Estimates But Faces Sliding Revenue And Mixed Outlook - Finimize
Teladoc Health Earnings: Not Dead Yet (NYSE:TDOC) - Seeking Alpha
Telemedicine Technology Markets Analysis Report 2025 | Market to Surpass $250 Billion by 2030, Driven by Virtual Consultations, Government Investment, and Emerging AI- and IoT-Powered Care Platforms - GlobeNewswire
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.97%
6.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):